Introduction: Chronic organ damages and complications have become one of the major problems concerning morbidity and mortality in systemic lupus erythematosus. Aims: Present study was to examine the frequencies and types of malignancies in a lupus population followed regularly in our department, and to find correlation between cancer-associated mortality and the use of immune suppressants. Methods and results: Authors analysed data 860 lupus patients from 1965 till the end of 2004. During study period 164 patients died, 18 of whom from cancer. The frequency of cancer-associated mortality was 11 % that was 2% of the total lupus population. Mortality has increased within 10-year periods reaching the maximum between 2001-2004 (8/24, 33%). Age of the 37 patients affected by malignancy was 47.7 (20-73) years. Cancers appeared 13.4 (1-45) years after the diagnosis of lupus. Breast cancer occurred most frequently (n = 11) followed by gastro-intestinal malignancies (n = 9), then cervix cancer and different hematologic malignancies (5-5 cases), bronchial cancer (n = 4) and skin, ovarian and vesical cancers (1-1-1 cases). Relative risk of non-Hodgkin lymphoma and cervix cancer increased significantly as compared to those of the Hungarian general female population. Before the cancer developed 62.2% of patients received azathioprine and/or cyclophosphamicle. Conclusion: Present results describe and analyse for the first time the association between lupus and malignant disorders in a Hungarian population calling the attention for the increased risk for the development of cancers and the importance of regular screening and extended examinations in SLE patients.
|Translated title of the contribution||The occurrence of malignancies in a Hungarian lupus population|
|Number of pages||5|
|Publication status||Published - Nov 19 2006|
ASJC Scopus subject areas